ArticleEndocrine pathology2020

Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin.

Carl Christofer Juhlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.